Femara Information:

Femara (Generic name: Letrozole) is a first-line chemotherapy drug to treat advanced breast cancer in postmenopausal women with hormone receptor positive or hormone receptor unknown locally advanced or metastatic breast cancer. Letrozole inhibits the enzyme aromatase in the adrenal glands that produces the estrogens (estradiol and estrone) and thereby lowers their levels. Letrozole is the only aromatase inhibitor approved in all three of the following setting: adjuvant therapy, extended adjuvant therapy and advanced breast cancer. Femara Letrozole significantly reduced the risk of cancer recurrence or spreading to another part of the body. Take Femara exactly as it was prescribed for you.

Femara Side Effects:

The most common Femara side effects are abdominal pain, bone or joint pain, constipation, diarrhea, fatigue, hair loss, headache, high cholesterol, hot flashes, loss of appetite, muscle pain, nausea, rash, vomiting, and etc. If you are experiencing any severe side effects such as blood clots, heart attack, osteoporosis, other cancer, stroke, vaginal bleeding, and serious allergic reaction (e.g., difficult breathing; hives; itching; rash; swelling of the lips, tongue or throat), please inform your doctor immediately.

Femara Precautions:

Do NOT take Femara oral if you are allergic to Letrozole or any of the ingredients in Femara medication. Do NOT take Femera if you are pregnant or breast-feeding. Femera is NOT recommended for women who have not yet started menopause, men or children. Femara may increase the risk of osteoporosis (bone loss). Before taking Femara pills, tell your doctor if you have had any medical conditions such as heart problem, osteoporosis, cholesterol, kidney or liver disease. Tell your doctor about all the prescription and over-the-counter (OTC) medications you use. They may interact with Femara drug, especially any estrogen-containing products (e.g., birth control pills, vaginal rings, estrogen cream and hormone replacement therapy).